Skip to main content
Medical information Clinical review pending

Genetic Testing

TP63 Gene Ankyloblepharon-Ectodermal Defects Cleft Lip/Palate Genetic Test

Genetic test to identify mutations in the TP63 gene associated with ankyloblepharon-ectodermal defects, cleft lip, and palate. Helps in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
A clinical history and genetic counseling session are recommended prior to testing. Discuss specific preparation needs with your doctor or the laboratory.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the TP63 Gene Ankyloblepharon-Ectodermal Defects Cleft Lip/Palate Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of ankyloblepharon-ectodermal defects
  • ✓Family history of cleft lip/palate
  • ✓Symptoms suggestive of ectodermal dysplasia
  • ✓Prenatal screening for related conditions
  • ✓Family planning with known genetic predisposition
02

In plain language

What this test helps you understand

Identifies mutations in the TP63 gene associated with ankyloblepharon-ectodermal defects, cleft lip, and palate, aiding in diagnosis and management.
The TP63 Gene Ankyloblepharon-Ectodermal Defects Cleft Lip/Palate NGS Genetic DNA Test is a specialized genetic analysis designed to detect mutations within the TP63 gene. This gene is important for the development of certain congenital conditions, such as ectodermal dysplasia, cleft lip, and palate. Understanding the genetic basis of these conditions is crucial for early diagnosis and appropriate medical management.

This test uses Next-Generation Sequencing (NGS) technology to examine the DNA for specific genetic changes in the TP63 gene. Identifying these mutations can help healthcare providers understand the underlying cause of a patient's condition.

This test may be considered for individuals with a family history of ankyloblepharon-ectodermal defects or cleft lip/palate, those showing symptoms suggestive of related genetic disorders, or parents planning a family with a known genetic predisposition.

Taking this test can lead to early identification of genetic conditions, support informed family planning decisions, and guide personalized medical management. Discussing the results with a healthcare professional is essential to understand their implications and plan next steps.

Confirm with the laboratory before booking for detailed information on pricing and availability.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history and genetic counseling session are recommended prior to testing. Discuss specific preparation needs with your doctor or the laboratory.
SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
MethodologyNext-Generation Sequencing (NGS) of the TP63 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the TP63 gene. It does not detect mutations in other genes that may cause similar conditions. Results must be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The TP63 gene provides instructions for making a protein important for the development of skin, hair, nails, teeth, and other parts of the body. Mutations in this gene can lead to conditions like ectodermal dysplasia, cleft lip, and palate.
Individuals with a family history of related conditions, those showing symptoms, or parents concerned about genetic risks may be recommended for this test. Consult your doctor.
The test involves analyzing a sample of your DNA (usually from blood) to look for specific changes in the TP63 gene using Next-Generation Sequencing (NGS).
Results indicate the presence or absence of specific mutations in the TP63 gene. A healthcare professional, often a genetic counselor or specialist, will explain the results and their implications.
Genetic counseling is recommended before and after testing to help understand the test, its implications, and the results. Confirm availability with the laboratory.
The typical turnaround time is 3 to 4 weeks, but this can vary. Confirm the current turnaround time with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp